MedTrace Logo

Effects of Intraoperative Blood and Blood Product Consumption on Postoperative Results in Pediatric Cardiac Surgery

NCT03291769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2019-10-17

No results posted yet for this study

Summary

Blood products and intravenous fluids are frequently used in the treatment of children who have undergone cardiac surgery in order to maintain hemodynamic stability. Optimal hematocrit values during CPB are still being discussed in children undergoing congenital cardiac surgery. The overall complication rate for transfusion in adults is 2.5 complications per 1000 units, while 10.7 complications per 1000 transfusion in children. The aim of this study is to investigate the effects of the our transfusion strategies used in pediatric cardiac surgery on duration of intensive care unit, duration of postoperative mechanical ventilation and mortality.

Conditions

  • Blood Loss, Surgical
  • Pediatric Heart Surgery

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Feri̇de Karacaer · Cukurova University

Eligibility

Min Age
1 Day
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-25
Primary Completion
2018-08-25
Completion
2018-12-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291769 on ClinicalTrials.gov